Events & Presentations

Investors

Events & Presentations

Upcoming Events
Date Event Details Remind Me
Nov 18, 2019
American Heart Association Scientific Sessions 2019

November 18, 9:32 a.m. EST – Dr. Christie Ballantyne, Baylor Coll Med, Houston, TX, will deliver an oral presentation titled, “RNA Interference Targeting Apolipoprotein C-III Results in Deep and Prolonged Reductions in Plasma Triglycerides”

November 18, 9:38 a.m. EST – Dr. Gerald Watts, Univ of Western Australia, Royal Perth Hosp, Perth, Australia, will deliver an oral presentation titled, “RNA Interference Targeting Hepatic Angiopoietin-Like Protein 3 Results in Prolonged Reductions in Plasma Triglycerides and LDL-C in Human Subjects”

Philadelphia
Nov 25, 2019 4:30 PM EST
Arrowhead Pharmaceuticals 2019 Year End Results
Archived Events
Date Event Details
May 10, 2018 4:15 PM PDT
Vascular Discovery: From Genes to Medicine – Scientific Sessions 2018
San Francisco
May 8, 2018 4:30 PM EDT
Arrowhead Fiscal 2018 Second Quarter Results
Apr 25, 2018 4:00 PM EDT
World Orphan Drug Congress USA 2018
Apr 12 - Apr 14, 2018
The EASL International Liver Congress™ 2018

Oral Presentations:

Development of subcutaneously administered RNAi therapeutic ARO-HBV for chronic hepatitis B virus infection

  • Presentation Reference: PS-030
  • Session: Parallel session: Parallel session: HBV Cure: Pre-clinical studies
  • Date and Time: April 12, 2018 at 5:15 p.m. CET
  • Authors: Christine Wooddell, et al.

ARO-AAT, a subcutaneous RNAi-based therapeutic for alpha-1 antitrypsin-related liver disease, demonstrates liver exposure-response and efficacy in preclinical studies

  • Presentation Reference: PS-147
  • Session: Parallel session: Clinical developments in metabolic and rare disease
  • Date and Time: April 14, 2018 at 9:15 a.m. CET
  • Authors: Christine Wooddell, et al.

Poster Presentation:

RNA interference therapy with ARC-520 Injection results in long term off-therapy antigen reductions in treatment naïve, HBeAg positive and negative patients with chronic HBV

  • Presentation Reference: FRI-362
  • Session: Viral hepatitis B/D: Therapy
  • Session Date and Time: April 13, 2018 from 9 a.m. to 5 p.m. CET
  • Authors: Man-Fung Yuen, et al.
Mar 29, 2018
American Society for Clinical Pharmacology & Therapeutics 2018 Annual Meeting
Mar 22, 2018
American Society for Clinical Pharmacology & Therapeutics 2018 Annual Meeting
Mar 13, 2018 1:35 PM EDT
Barclays Global Healthcare Conference 2018
Miami
Feb 27 - Mar 1, 2018 12:00 AM EST
AsiaTIDES: Oligonucleotide and Peptide Therapeutics
Kyoto, Japan
Feb 22, 2018 3:10 PM UTC
SMI RNA Therapeutics Conference
London
Feb 9, 2018 4:30 PM EST
Arrowhead Fiscal 2018 First Quarter Results